3 Health Services Stocks On The Rise

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 126 points (-0.8%) at 15,723 as of Friday, Jan. 31, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,087 issues advancing vs. 1,837 declining with 186 unchanged.

The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.5%. A company within the industry that increased today was HCA Holdings ( HCA), up 1.2%. On the negative front, top decliners within the industry include Hanger ( HGR), down 14.3%, C.R. Bard ( BCR), down 2.5%, Intuitive Surgical ( ISRG), down 1.6%, CareFusion ( CFN), down 1.5% and Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.5%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Accuray ( ARAY) is one of the companies pushing the Health Services industry higher today. As of noon trading, Accuray is up $1.01 (10.9%) to $10.25 on heavy volume. Thus far, 5.9 million shares of Accuray exchanged hands as compared to its average daily volume of 970,100 shares. The stock has ranged in price between $10.00-$10.71 after having opened the day at $10.14 as compared to the previous trading day's close of $9.24.

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. Accuray has a market cap of $667.9 million and is part of the health care sector. Shares are up 2.5% year-to-date as of the close of trading on Thursday. Currently there are 5 analysts who rate Accuray a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Accuray as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally high debt management risk. Get the full Accuray Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Community Health Systems ( CYH) is up $0.76 (1.9%) to $41.07 on light volume. Thus far, 465,042 shares of Community Health Systems exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $40.04-$41.08 after having opened the day at $40.06 as compared to the previous trading day's close of $40.31.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. Community Health Systems has a market cap of $3.8 billion and is part of the health care sector. The company has a P/E ratio of 21.2, above the S&P 500 P/E ratio of 17.7. Shares are up 2.6% year-to-date as of the close of trading on Thursday. Currently there are 11 analysts who rate Community Health Systems a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Community Health Systems as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Community Health Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Laboratory Corporation of America Holdings ( LH) is up $0.77 (0.9%) to $89.83 on average volume. Thus far, 407,057 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $88.91-$90.20 after having opened the day at $90.15 as compared to the previous trading day's close of $89.06.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $7.8 billion and is part of the health care sector. The company has a P/E ratio of 14.7, below the S&P 500 P/E ratio of 17.7. Shares are down 2.5% year-to-date as of the close of trading on Thursday. Currently there are 3 analysts who rate Laboratory Corporation of America Holdings a buy, 1 analyst rates it a sell, and 13 rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, notable return on equity, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Laboratory Corporation of America Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists